Composition and Formulation

Actrapid contains human insulin, produced using recombinant DNA technology in yeast (Saccharomyces cerevisiae), making it structurally and functionally similar to natural insulin. It is available as a solution for injection in vials, cartridges (Penfill), or prefilled pens (NovoLet, InnoLet, FlexPen) at a concentration of 100 international units (IU) per milliliter.The solution is clear, colorless, and aqueous.

Therapeutic Uses

Actrapid is indicated for the treatment of: Type 1 diabetes mellitus (insufficient pancreatic insulin production) Type 2 diabetes mellitus (ineffective use of insulin) Gestational diabetes Complications such as diabetic ketoacidosis and hyperosmolar hyperglycemic states.

AVAILABLE AT YASSIR PHARMACY, ACCRA ROAD- DELIVERIES DONE